Florida Cancer Specialists & Research Institute

Articles

Florida Cancer Specialists & Research Institute Expands Access to Gynecologic Oncology in Palm Beach County

July 12th 2022

Florida Cancer Specialists & Research Institute has expanded access to specialized gynecologic oncology care with the addition of Board-certified gynecologic oncologist Christopher McCann, DO.

Florida Cancer Specialists & Research Institute Expands Access to Cancer Care in Central Florida with Opening of Kissimmee Cancer Center

July 6th 2022

Florida Cancer Specialists & Research Institute, LLC held a ribbon-cutting ceremony on June 16, 2022 to celebrate the opening of a new clinical site in Kissimmee, FL.

Florida Cancer Specialists & Research Institute Welcomes Medical Oncologist Richard McDonough, MD

June 28th 2022

Florida Cancer Specialists & Research Institute welcomes Board-certified medical oncologist Richard McDonough, MD to the statewide practice.

Florida Cancer Specialists & Research Institute Participates in Global Gathering to Share Advances in Oncology Pharmacy Services

June 24th 2022

Florida Cancer Specialists & Research Institute clinicians and leaders shared the latest advances in oncology pharmacy operations and dispensing practices at the National Community Oncology Dispensing Association 2022 Spring Forum held last month in Atlanta.

Florida Cancer Specialists & Research Institute Expands Care With New Cancer Center Location in Lee County

June 21st 2022

Florida Cancer Specialists & Research Institute, LLC has opened a new state-of-the-art facility at 8981 Colonial Center Drive in Fort Myers to provide comprehensive treatments and a variety of services to adults with cancer and other diseases.

Martin Dietrich, MD, PhD Named 2022 Leukemia & Lymphoma Society of Orlando’s Man of the Year

June 13th 2022

Martin Dietrich, MD, PhD, of Florida Cancer Specialists, has been named the 2022 Man of the Year by the Orlando Chapter of the Leukemia & Lymphoma Society.

Florida Cancer Specialists & Research Institute Welcomes Medical Oncologist Ibrahim Sadek, MD to The Villages

June 9th 2022

Medical oncologist Ibrahim Sadek, MD has joined Florida Cancer Specialists & Research Institute.

Oncology Nurses Recognized for Excellence in Patient Care, Advocacy and Leadership

June 1st 2022

Each May during Oncology Nursing Month, Florida Cancer Specialists & Research Institute, LLC recognizes two outstanding nurses within the practice.

Michael Diaz, MD, Recognized by Florida Society of Clinical Oncology For Advocacy Achievements & Leadership

May 24th 2022

Medical oncologist Michael Diaz, MD, President & Managing Physician of Florida Cancer Specialists & Research Institute, LLC, is the recipient of the Florida Society of Clinical Oncology Dorothy Green Phillips Legacy Award 2022.

Advancing Cancer Care Through Clinical Trials in a Community Oncology Setting

May 10th 2022

The American Cancer Society reported earlier this year that the risk of dying from cancer in the United States has decreased by 32% over the past 28 years, which translates to almost 3.5 million fewer cancer deaths.

Florida Cancer Specialists & Research Institute Physicians Serve as Panelists for FLASCO Training Program

April 25th 2022

Two medical oncologists from Florida Cancer Specialists & Research Institute participated in the Florida Society of Clinical Oncology Fellow & Resident Educational Training Program. The program featured respected keynote speakers to share helpful information for transitioning into the oncology workforce.

Florida Cancer Specialists & Research Institute Launches FCS Hematology Oncology Review

April 4th 2022

Florida Cancer Specialists & Research Institute launched a new website to host a variety of top articles ranging from recent oncology and hematology studies to new therapies, even topics on value-based care.

Margarett Ellison, MD, Named National Gynecologic Oncology Observation Site

March 31st 2022

Margarett Ellison, MD, gynecologic oncologist with Gynecologic Oncology of Tallahassee, A Division of Florida Cancer Specialists & Research Institute, has been designated as a National GYN Oncology Observation Site for Intuitive Surgical.

Florida Cancer Specialists & Research Institute Welcomes Ken Sturtz, MBA, MHA as Chief Information Officer

March 28th 2022

Florida Cancer Specialists and Research Institute welcomed Ken Sturtz, MBA, MHA to its executive leadership team as Chief Information Officer.

Florida Cancer Specialists and Research Institute Announces Senior Leadership Appointment

March 10th 2022

Joshua Eaves joined the Florida Cancer Specialists & Research Institute senior management team as senior vice president, corporate development.

Pharmacists in the Front-Line: The Fight Against Cancer

February 22nd 2022

Skill, passion and teamwork. Essential elements for patient centered partnerships.

Advancing Therapies for Patients Through Clinical Research in Community Oncology Practices

February 15th 2022

The survival rate for Americans diagnosed with several of the most common cancers has increased dramatically in the past nearly three decades, thanks in large part to scientific discoveries and treatment advances.

Oncology Nurse Recognized as Metastatic Breast Cancer Survivor

January 20th 2022

Florida Cancer Specialists Nurse Receives Inaugural MBC Heroes™ Award from CURE Media Group.

Florida Cancer Specialists & Research Institute Breast Cancer Partnership Receives National Accreditation

November 12th 2021

Florida Cancer Specialists & Research Institute, in collaboration with AdventHealth Heart of Florida and Central Florida Cancer Institute, has received a three-year accreditation from the National Accreditation Program for Breast Centers, a quality program of the American College of Surgeons.

Gustavo Fonseca, MD, FACP, Manish Patel, MD, and James Reeves, MD, Co-Author Integrated Safety Analysis of Umbralisib in Lymphoid Malignancies

October 22nd 2021

Three medical oncologists at Florida Cancer Specialists & Research Institute are co-authors on a new integrated safety analysis of umbralisib, used to treat lymphoid malignancies.